Fujita Health University · International Center for Regenerative Medicine

Research keywordsCAR NK cells・multiple myeloma・immune checkpoint inhibition・PD-L1 targeting・siRNA therapeutics・hematologic malignancies

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.2025
• Successful Treatment of Peripheral T-cell Lymphoma Not Otherwise Specified in Bilateral Subconjunctiva: A Case Report2025
• Monoallelic mutations in MMD2 cause autosomal dominant aggressive periodontitis.2025
• Characteristics and utilization of the three BCMA-targeted therapies in multiple myeloma2025

• 白血病、脳腫瘍、肉腫、芽腫に幅広く使える大量生産型CAR-NK細胞療法の開発2025
• 骨軟部腫瘍における間葉系幹細胞マーカーMeflinの機能解析と治療法の開発研究2023
• マクロファージ活性化のkey分子CD47およびCD24に対するCARバックボーンベクターの開発2023
• 多発性骨髄腫のマクロファージ活性化と協調効果を示すiPSキラーCAR-Tの開発2022

• Official profile